Literature DB >> 15199132

DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.

Milota Kaluzová1, Stefan Kaluz, Michael I Lerman, Eric J Stanbridge.   

Abstract

We investigated the relationship between the tumor suppressor p53 and the hypoxia-inducible factor-1 (HIF-1)-dependent expression of the hypoxia marker, carbonic anhydrase IX (CAIX). MCF-7 (wt p53) and Saos-2 (p53-null) cells displayed similar induction of CAIX expression and CA9 promoter activity under hypoxic conditions. Activation of p53 by the DNA damaging agent mitomycin C (MC) was accompanied by a potent repression of CAIX expression and the CA9 promoter in MCF-7 but not in Saos-2 cells. The activated p53 mediated increased proteasomal degradation of HIF-1alpha protein, resulting in considerably lower steady-state levels of HIF-1alpha protein in hypoxic MCF-7 cells but not in Saos-2 cells. Overexpression of HIF-1alpha relieved the MC-induced repression in MCF-7 cells, confirming regulation at the HIF-1alpha level. Similarly, CA9 promoter activity was downregulated by MC in HCT 116 p53(+/+) but not the isogenic p53(-/-) cells. Activated p53 decreased HIF-1alpha protein levels by accelerated proteasome-dependent degradation without affecting significantly HIF-1alpha transcription. In summary, our results demonstrate that the presence of wtp53 under hypoxic conditions has an insignificant effect on the stabilization of HIF-1alpha protein and HIF-1-dependent expression of CAIX. However, upon activation by DNA damage, wt p53 mediates an accelerated degradation of HIF-1alpha protein, resulting in reduced activation of CA9 transcription and, correspondingly, decreased levels of CAIX protein. A model outlining the quantitative relationship between p53, HIF-1alpha, and CAIX is presented.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15199132      PMCID: PMC480909          DOI: 10.1128/MCB.24.13.5757-5766.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

Review 1.  The complexity of p53 modulation: emerging patterns from divergent signals.

Authors:  A J Giaccia; M B Kastan
Journal:  Genes Dev       Date:  1998-10-01       Impact factor: 11.361

2.  p53 inhibits hypoxia-inducible factor-stimulated transcription.

Authors:  M V Blagosklonny; W G An; L Y Romanova; J Trepel; T Fojo; L Neckers
Journal:  J Biol Chem       Date:  1998-05-15       Impact factor: 5.157

3.  p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene.

Authors:  F Agani; D G Kirsch; S L Friedman; M B Kastan; G L Semenza
Journal:  Cancer Res       Date:  1997-10-15       Impact factor: 12.701

4.  Regulation of p53 stability by Mdm2.

Authors:  M H Kubbutat; S N Jones; K H Vousden
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

Review 5.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

Authors:  J M Brown; A J Giaccia
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

6.  p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.

Authors:  X Chen; L J Ko; L Jayaraman; C Prives
Journal:  Genes Dev       Date:  1996-10-01       Impact factor: 11.361

7.  Up-regulation of p53 by antisense expression of HPV18 E6 oncogene does not influence the level of MN/CA IX tumor-associated protein in HeLa cervical carcinoma cells.

Authors:  J Lieskovská; M Kaluzova; R Opavsky; S Kaluz; J Pastorek; R Kettmann; S Pastoreková
Journal:  Int J Oncol       Date:  1998-11       Impact factor: 5.650

8.  Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes.

Authors:  S V Ivanov; I Kuzmin; M H Wei; S Pack; L Geil; B E Johnson; E J Stanbridge; M I Lerman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

9.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.

Authors:  T G Graeber; C Osmanian; T Jacks; D E Housman; C J Koch; S W Lowe; A J Giaccia
Journal:  Nature       Date:  1996-01-04       Impact factor: 49.962

10.  MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas.

Authors:  C Zietz; M Rössle; C Haas; A Sendelhofert; A Hirschmann; M Stürzl; U Löhrs
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

View more
  37 in total

Review 1.  Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?

Authors:  Stefan Kaluz; Milota Kaluzová; Shu-Yuan Liao; Michael Lerman; Eric J Stanbridge
Journal:  Biochim Biophys Acta       Date:  2009-01-22

2.  Rational design of minimal hypoxia-inducible enhancers.

Authors:  Stefan Kaluz; Milota Kaluzová; Eric J Stanbridge
Journal:  Biochem Biophys Res Commun       Date:  2008-04-08       Impact factor: 3.575

Review 3.  Metabolic modulation of cancer: a new frontier with great translational potential.

Authors:  Adam Kinnaird; Evangelos D Michelakis
Journal:  J Mol Med (Berl)       Date:  2015-01-14       Impact factor: 4.599

4.  Expression of HIF-1α ODD domain fused canine caspase 3 by EGFR promoter-driven adenovirus vector induces cytotoxicity in canine breast tumor cells under hypoxia.

Authors:  Mariko Okamoto; Ai Asamura; Ko Tanaka; Takefumi Soeda; Kyo Watanabe; Hiroyuki Mizuguchi; Teruo Ikeda
Journal:  Vet Res Commun       Date:  2016-10-16       Impact factor: 2.459

5.  p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1α-mediated down-regulation of CXCL12.

Authors:  Kensuke Kojima; Teresa McQueen; Ye Chen; Rodrigo Jacamo; Marina Konopleva; Naoki Shinojima; Elizabeth Shpall; Xuelin Huang; Michael Andreeff
Journal:  Blood       Date:  2011-08-25       Impact factor: 22.113

6.  Carbon nanotubes induce malignant transformation and tumorigenesis of human lung epithelial cells.

Authors:  Liying Wang; Sudjit Luanpitpong; Vincent Castranova; William Tse; Yongju Lu; Varisa Pongrakhananon; Yon Rojanasakul
Journal:  Nano Lett       Date:  2011-06-09       Impact factor: 11.189

Review 7.  Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke.

Authors:  Honglian Shi
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

8.  Involvement of histone deacetylation in MORC2-mediated down-regulation of carbonic anhydrase IX.

Authors:  Yangguang Shao; Yan Li; Jian Zhang; Di Liu; Furong Liu; Yue Zhao; Tao Shen; Feng Li
Journal:  Nucleic Acids Res       Date:  2010-01-27       Impact factor: 16.971

9.  Inhibition of hypoxia-inducible factor-1alpha (HIF-1alpha) protein synthesis by DNA damage inducing agents.

Authors:  Jessica Jie Wei Lou; Yee Liu Chua; Eng Hui Chew; Jie Gao; Martin Bushell; Thilo Hagen
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

10.  Complex regulation of the transactivation function of hypoxia-inducible factor-1 alpha by direct interaction with two distinct domains of the CREB-binding protein/p300.

Authors:  Jorge L Ruas; Utta Berchner-Pfannschmidt; Sohail Malik; Katarina Gradin; Joachim Fandrey; Robert G Roeder; Teresa Pereira; Lorenz Poellinger
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.